Scient’x, has launched its new Tribeca cage system, which allows the surgeon to utilize a unilateral transforaminal approach to interbody cage insertion to minimise dural exposure.
The Scient’x Tribeca cage implants are indicated for use with autogenous bone graft as an intervertebral body fusion device at either one or two contiguous levels in the lumbosacral spine, from L2 to S1, for the treatment of degenerative disc disease (DDD) with up to Grade I spondylolisthesis.
The Tribeca cage is to be used in skeletally mature patients who have had six months of non-operative care. It is implanted using an anterior approach or posterior approach and is intended to be used single or in pairs with ISOBAR 6.2mm hemispherical screws with offset clamps and 5.5mm rods.
“The Tribeca cage was designed to be a user-friendly solution to a transforaminal approach,” said Dr Antonio Castellvi, one of the designing surgeons. “It offers four different angles of insertion which gives the surgeon intra-operative options for placement of the device.” Dr. Marc Weinstein, another designing surgeon, commented, “There are twenty four different sizes offered in this system, which gives me a great amount of flexibility in adapting to unique patient anatomy.”